Life Sciences Academy | Navigating Regulatory and IP Challenges in European M&A

LSH Academy icon 400px

Please join us for an exclusive one hour webinar, where we will be approaching the session from the structure of a typical acquisition process of target companies active in the Life Sciences sector. We will discuss regulatory and IP items that we often encounter in Europe and we will explain how they can impact the overall acquisition process and timing.

Discussion topics will include:

  • Recommendations for including regulatory and IP items in the term sheet.
  • The appropriate scope of involvement required from regulatory and IP specialists during the due diligence process.
  • What regulatory and IP issues are often discovered in Europe and how can these issues be addressed in the acquisition documents.
  • The allocation of liability for regulatory and IP items in the acquisition documents.
  • What regulatory and IP items can become a condition to the transaction proceeding and how much time it can take to satisfy such conditions.
  • Once the transaction had been completed, what regulatory and IP actions do we see post-completion and how to make a success of these post-completion actions.
  • What regulatory and IP items can be high0risk items for post-acquisition claims?

After the webinar, you should be able to better understand and anticipate regulatory and IP issues that can arise when acquiring or divesting European companies active in the Life Sciences sector.

Future Life Sciences Academy Webinars
Watch our previous LS Academy Webinars:

 

Register here

Register here
Share
When
Start
End
16:00 - 17:00 GMT

Connect with one of our experts